Metformin News and Research

RSS

Metformin is the active ingredient in a drug used to treat diabetes mellitus (a condition in which the body cannot control the level of sugar in the blood). It is also being studied in the treatment of cancer. It decreases the amount of glucose (a type of sugar) released into the bloodstream from the liver and increases the body’s use of the glucose. Metformin is a type of antidiabetic agent.

Blood sugar levels linked to DNA damage and cancer in diabetics

Increased blood sugar levels in diabetics could damage DNA and make the genome unstable, increasing the risk of certain cancers.

26 Aug 2019

Study shows how cigarette smoke drives tumor aggressiveness in head and neck cancer

Head and neck cancer is the sixth most common cancer in the world. The vast majority of cases are head and neck squamous cell carcinoma, a type of cancer that arises in the outer layer of the skin and mucous membranes of the mouth, nose and throat.

8 Aug 2019

SGLT-2 inhibitors do not increase the risk of UTIs in diabetics, concludes study

A new study has shown that SGLT-2 inhibitors used in the treatment of type 2 diabetes do not increase the risk of UTIs over other anti-diabetic medications.

31 Jul 2019

Metformin use linked to lower risk of dementia in African Americans with type 2 diabetes

A large observational cohort study examining male veterans aged over 50 years with type 2 diabetes found that metformin use was associated with a significantly lower risk of dementia in African American patients.

11 Jul 2019

Diabetes drug can halve the risk of late miscarriage, preterm births for women with PCOS

Metformin can halve the risk of late miscarriage and preterm births for women with polycystic ovary syndrome.

24 Jun 2019

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes.

18 Jun 2019

No lasting improvement in insulin secretion with diabetic medication

Adults with type 2 diabetes mellitus respond to medical treatment by producing more insulin, but there is no long-term effect on insulin secretion after treatment stops, concluded a pair of clinical trials.

9 Jun 2019

Vitamin D supplement does not prevent type 2 diabetes in adults at high risk, study finds

Taking a daily vitamin D supplement does not prevent type 2 diabetes in adults at high risk, according to results from a study funded by National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health.

8 Jun 2019

Diabetes drug reduces anxiety-like behaviors in mice

The antidiabetic medication metformin reduces anxiety-like behaviors in male mice by increasing serotonin availability in the brain, according to a study published in JNeurosci.

From Society for Neuroscience 4 Jun 2019

Drug routines of children with type 1 diabetes are disrupted during holidays

Children with type 1 diabetes find it difficult to adhere to their drug routines during school holidays and weekends.

23 May 2019

Discovery could change the way fibromyalgia and chronic pain are treated

Researchers led by a team from The University of Texas Medical Branch at Galveston were able to dramatically reduce the pain of fibromyalgia patients with medication that targeted insulin resistance.

7 May 2019

Study results of a potential drug to treat Type 2 diabetes in children announced

Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced Sunday [April 28] at the Pediatric Academic Societies 2019 meeting in Baltimore, Md. The New England Journal of Medicine also published the findings.

29 Apr 2019

Metformin News and Research

Further Reading

Blood sugar levels linked to DNA damage and cancer in diabetics

Study shows how cigarette smoke drives tumor aggressiveness in head and neck cancer

SGLT-2 inhibitors do not increase the risk of UTIs in diabetics, concludes study

Metformin use linked to lower risk of dementia in African Americans with type 2 diabetes

Diabetes drug can halve the risk of late miscarriage, preterm births for women with PCOS

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

No lasting improvement in insulin secretion with diabetic medication

Vitamin D supplement does not prevent type 2 diabetes in adults at high risk, study finds

Diabetes drug reduces anxiety-like behaviors in mice

Drug routines of children with type 1 diabetes are disrupted during holidays

Discovery could change the way fibromyalgia and chronic pain are treated

Study results of a potential drug to treat Type 2 diabetes in children announced

New review on relationship between COPD and Type 2 diabetes

Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients

Common drug may lead to obesity in offspring

Medication could mitigate side effects of chemotherapy for breast cancer patients

Medical treatment for gestational diabetes could prevent long-term complications in children

Research shows how SGLT-2 inhibitors induce a fasting state that triggers metabolic benefits

Patients experiment with prescription drugs to fight aging

Study to generate evidence on impact of pharmaceutical industry-led medicines access program

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News